Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation

Robert O. Bonow; Adrian F. Hernandez; Mintu Turakhia

doi:10.1001/jamacardio.2020.1782

Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation

Robert O. Bonow^*, Adrian F. Hernandez, Mintu Turakhia

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Editorial › peer-review

25 Scopus citations

Original language	English (US)
Pages (from-to)	986-987
Number of pages	2
Journal	JAMA cardiology
Volume	5
Issue number	9
DOIs	https://doi.org/10.1001/jamacardio.2020.1782
State	Published - Sep 2020

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1001/jamacardio.2020.1782

Cite this

@article{9de5ab0d05e94a64a185e28307fa7ba5,

title = "Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation",

author = "Bonow, {Robert O.} and Hernandez, {Adrian F.} and Mintu Turakhia",

note = "Funding Information: reported receiving funds from the Patient-Centered Outcome Research Institute for a clinical trial of hydroxychloroquine to evaluate the efficacy of preexposure prophylaxis among health care workers. Dr Turakhia reported grants from Apple Inc and the American Heart Association and other support from AliveCor outside the submitted work. No other disclosures were reported.",

year = "2020",

month = sep,

doi = "10.1001/jamacardio.2020.1782",

language = "English (US)",

volume = "5",

pages = "986--987",

journal = "JAMA cardiology",

issn = "2380-6583",

publisher = "American Medical Association",

number = "9",

}

TY - JOUR

T1 - Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation

AU - Bonow, Robert O.

AU - Hernandez, Adrian F.

AU - Turakhia, Mintu

N1 - Funding Information: reported receiving funds from the Patient-Centered Outcome Research Institute for a clinical trial of hydroxychloroquine to evaluate the efficacy of preexposure prophylaxis among health care workers. Dr Turakhia reported grants from Apple Inc and the American Heart Association and other support from AliveCor outside the submitted work. No other disclosures were reported.

PY - 2020/9

Y1 - 2020/9

UR - http://www.scopus.com/inward/record.url?scp=85084349123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85084349123&partnerID=8YFLogxK

U2 - 10.1001/jamacardio.2020.1782

DO - 10.1001/jamacardio.2020.1782

M3 - Editorial

C2 - 32936259

AN - SCOPUS:85084349123

SN - 2380-6583

VL - 5

SP - 986

EP - 987

JO - JAMA cardiology

JF - JAMA cardiology

IS - 9

ER -

Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this